Osteitis fibrosa cystica is a skeletal disorder resulting in a loss of bone mass, a weakening of the bones as their calcified supporting structures are replaced with fibrous tissue, called peritrabecular fibrosis, and the formation of cyst-like brown tumors in and around the bone. It is caused by hyperparathyroidism, a surplus of parathyroid hormone from over-active parathyroid glands, which activates bone-breaking cells called osteoclasts through a process called osteoclastic bone resorption, releasing minerals such as calcium into the bloodstream. Symptoms follow from both the general softening of the bones and the excess calcium in the blood, and include bone fractures, kidney stones, nausea, a moth-eaten appearance in the bones, appetite loss and weight loss. The disease is currently detected through a combination of blood testing, X-rays and tissue sampling. Before 1950 roughly half of hyperparathyroidism cases in the United States progressed to this disease, but improved early detection has made it increasingly rare in developed nations.
Facts
Classification
ICD-10 ChapterIV: Endocrine, Nutritional and Metabolic Diseases 1 Communicable or Non-communicable Transmission Route Causative Agent
Causative Agent (category)Complication of Another Disease 1 First Described Sources
1. Osteitis fibrosa cystica (Wikipedia)
Lead section, opening sentence
a skeletal disorder resulting in a loss of bone mass
Lead section, cause paragraph
caused by hyperparathyroidism, which is a surplus of parathyroid hormone from over-active parathyroid glands
Lead section, cause paragraph [disease-category]
caused by hyperparathyroidism
Infobox, Specialty field
Specialty: Endocrinology
Section: History (first-described-year)
The condition was first described by Gerhard Engel in 1864 and Friedrich Daniel von Recklinghausen in 1890, though William Hunter, who died in 1783, is credited with finding the first example of the disease.
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.